Imaging Evaluation for Palpable Breast Masses in Young Women

Age-Based Imaging Approach

For women younger than 30 years of age, ultrasound is recommended as the first-line imaging investigation for palpable breast masses due to the low incidence of breast cancer (<1%) in this age group and the theoretical increased radiation risk of mammography, as recommended by the American College of Radiology 1, 2
The American College of Radiology Appropriateness Criteria specifically recommends ultrasound as the primary imaging modality for women under 30 years with palpable breast masses 1

Most benign lesions in young women are not well visualized on mammography, making ultrasound more effective for characterization 1

If ultrasound reveals suspicious findings in a woman younger than 30 years, diagnostic mammography may then be appropriate to better delineate disease extent and identify features of malignancy that may be seen only on mammography, as suggested by the American College of Radiology 1, 2
Mammography should not be used as the initial imaging modality in younger women due to the theoretically increased radiation risk and low incidence of breast cancer in this population, according to the American College of Radiology 2

If ultrasound demonstrates a clearly benign finding, clinical follow-up is appropriate, and further imaging or tissue sampling is usually not indicated, as recommended by the American College of Radiology 2
If ultrasound reveals suspicious features, tissue sampling (ultrasound-guided core biopsy) is warranted, with core biopsy being superior to fine-needle aspiration in terms of sensitivity, specificity, and correct histological grading of palpable masses 1, 2, 3

A palpable mass that persists throughout a complete menstrual cycle requires imaging evaluation, as cyclical breast changes typically resolve after 1-2 menstrual cycles 4
Despite negative imaging, a suspicious dominant palpable finding should still undergo further evaluation, as physical examination findings should never be overruled by negative imaging, according to the American College of Radiology 5
The negative predictive value of imaging for cancer in the evaluation of a palpable lump is very high (97.4-100%), which may reassure women with low-suspicion palpable findings, as reported by the American College of Radiology 5

Relying solely on physical examination findings without imaging evaluation, as significant disagreement can occur even among experienced examiners, as noted by the American College of Radiology 5, 6
Proceeding directly to biopsy without imaging, as changes related to the biopsy may confuse, alter, obscure, or limit subsequent image interpretation, according to the American College of Radiology 1, 6
Using advanced imaging modalities like MRI, PET, or molecular breast imaging for initial evaluation of palpable masses, as these are not supported by evidence, as stated by the American College of Radiology 2